Indirect Sympathomimetics. Selective a1 agonists. Select alpha 2 agonists and drugs acting on the imidazoline receptors. Flashcards
Indirect sympathomimetics: Name the Releasers
- Amphetamine
- Tyramine
- Ephedrine
- Norpseudoephedrine
- Modanifil
- Methylfenidate
- Dexmethylfenidate
Amphetamine
- Action
- Clinical use
- Characteristics
- Amphetamine is an indirect sympathomimetic
- It promotes the release of NT from the nerve terminals
Action:
- Amphetamine increases the BP - (via a1 (vasculature) and b1 (heart) stimulation)
- Psychostimulant: it is a mood stimulant and increases alertness
- When it is abused it can result in euphoria
- Decreases appetite
Clinical use:
- ADHD
Characteristic:
- Orally active
- Long action of duration
- Enters CNS very easily and releases biological amines
Tyramine:
- Clinical use
- Characteristics
- Treatment
- Tyramine is a releaser
Clinical use:
- It is not clinically used
Characteristics:
- Tyramine is present in foods such as cheese and red wine.
- It is metabolised and inactivated by MAO-A in the GIT
- On those in MAO-A inhibitors that injest tyramine means that tyramine is not inactivated by MAO-A and therefore tyramine reaches the systemic circulation and increases the sympathetic tone by releasing NE
- Results in hypertensive crisis
Treatment:
- Treatment of tyramine induced hypertensive crisis is Phentolamine (a non selective alpha receptor antagonist)
Norpseudoephedrine:
- Clinical use
- Characteristic
- Norpseudoephedrine is a releaser
Clinical use:
- Nasal decongestant
Characteristics:
- Used with ibroprofen and antihistamines
Modanifil
- Clinical use
- Modanifil is a releaser
Clinical use:
- Narcolepsy
Methylfenidate
- Clinical use
- Methylfenidate is a releaser
Clinical use:
- ADHD
Dexmethylfenidate
- Clinical use
- Dexmethylfenidate is a releaser
Clinical use:
- ADHD
Cocaine:
- Action
- Clinical use
- Adverse effects
- Treatment
- Cocaine is a reuptake inhibitor
Action:
- It blocks dopamine and NE reuptake by blocking the Na+/K+ ATPase in the CNS and the periphery
- Its sympathomimetic actions in the CNS result in euphoria
Clinical use:
- Local anaesthetic
Adverse effects:
- Nasal septum perforation - this is because it also has intrinsic alpha 1 receptor agonist action and therefore causes vasoconstriction leading to nasal ischemia.
- Dilated cardiomyopathy
- Drug abuse
Treatment:
- Phentolamine
TCA: Desipramine and Amitriptyline
- Action
- Clinical use
- Adverse effects
- TCAs are reuptake inhibitors
Action:
- They block NE reuptake in the CNS and the periphery
Clinical use:
- Depression
Adverse effects:
- Arrhythmias
- Change in BP
- alpha and M blockers may complicate their autonomic actions
Name the TCA
- Amitryptyline
- Desipramine
Name the irreversible non-selective MAO inhibitors
- Tranylcypromine
- Phenelzine
- Pargyline
What is are Tranylcypromine, Phenelzine and Pargyline used for?
Why are they no longer recommended?
- Depression
- No longer used as they are non-selective MAO inhibitors so the ingestion of Tyramine can result in Hypertensive crisis
Name the irreversible MAO-B inhibitors
Selegiline
What is Selegiline used for?
Parkinsons
What type of MAO inhibitor is Selegiline?
Irreversible MAO-B inhibitor
What does MAO-A metabolise?
NE and serotonin
What does MAO-B metabolise?
Dopamine and tyramine
Name the reversible MAO-A inhibitors
Moclobemid
What is Moclobemid used for?
Mental depression
What type of MAO inhibitor is Moclobed?
Reversible MAO-A inhibitor
What are the selective alpha 1 agonists?
Phenylephrine
Methoxamine
Midodrine
Phenylephrine
- Action
- Clinical use
- Characteristics
Action:
- Phenylephrine is a selective alpha 1 receptor agonist
- It results in vasoconstriction which increases BP
Clinical use:
- Nasal decongestant (topical or oral)
- Ophthalmologic use (mydriasis without cycloplegia)
- Hypovolemia or shock: increased SBP and DBP results in reflex bradycardia
Characteristics:
- Not used as a systemic drug as it is dangerous
- It replaces pseudoephedrine as a nasal decongestant
- It is not inactivated by COMT as it is a catechol derivative